CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning of the year at Dec. 31, 2018	$ 36,223	$ 56,303,061	$ (51,787,947)	$ 4,551,337
Balance at the beginning of the year (in Shares) at Dec. 31, 2018	36,222,752
Sale of common stock, net of issuance costs	$ 3,000	503,615		506,615
Sale of common stock, net of issuance costs (in shares)	3,000,000
Common stock issued upon exercise of stock options	$ 270	188,500		188,770
Common stock issued upon exercise of stock options (in shares)	269,728
Warrants issued with Notes		392,000		392,000
Common stock issued for property and equipment	$ 5	7,995		8,000
Common stock issued for property and equipment (in shares)	5,000
Stock options granted to employees and consultants		2,924,841		2,924,841
Net loss			(9,662,819)	(9,662,819)
Balance at the end of the year at Sep. 30, 2019	$ 39,498	60,320,012	(61,450,766)	(1,091,256)
Balance at the end of the year(in Shares) at Sep. 30, 2019	39,497,480
Balance at the beginning of the year at Jun. 30, 2019	$ 39,303	59,061,513	(59,196,444)	(95,628)
Balance at the beginning of the year (in Shares) at Jun. 30, 2019	39,302,752
Common stock issued upon exercise of stock options	$ 195	131,950		132,145
Common stock issued upon exercise of stock options (in shares)	194,728
Warrants issued with Notes		392,000		392,000
Stock options granted to employees and consultants		734,549		734,549
Net loss			(2,254,322)	(2,254,322)
Balance at the end of the year at Sep. 30, 2019	$ 39,498	60,320,012	(61,450,766)	(1,091,256)
Balance at the end of the year(in Shares) at Sep. 30, 2019	39,497,480
Balance at the beginning of the year at Dec. 31, 2019	$ 39,498	61,468,034	(67,271,744)	(5,764,212)
Balance at the beginning of the year (in Shares) at Dec. 31, 2019	39,497,480
Sale of common stock, net of issuance costs	$ 7,575	3,092,425		3,100,000
Sale of common stock, net of issuance costs (in shares)	7,574,745
Common stock issued upon conversion of debt	$ 2,215	954,841		957,056
Common stock issued upon conversion of debt (in shares)	2,215,892
Common stock issued for acquisition of SevenFive Farms	$ 8,859	1,894,522		1,903,381
Common stock issued for acquisition of SevenFive Farms (in shares)	8,859,117
Beneficial conversion feature		233,500		233,500
Warrants exercised	$ 200	172,041		172,241
Warrants exercised (in shares)	200,000
Warrants issued with Notes		835,499		835,499
Cashless exercise of warrants	$ 374	821,164		821,538
Cashless exercise of warrants (in shares)	373,340
Stock options granted to employees and consultants		1,347,688		1,347,688
Net loss			(4,529,546)	(4,529,546)
Balance at the end of the year at Sep. 30, 2020	$ 58,721	70,819,714	(71,801,290)	(922,855)
Balance at the end of the year(in Shares) at Sep. 30, 2020	58,720,574
Balance at the beginning of the year at Jun. 30, 2020	$ 51,189	67,406,256	(71,226,830)	(3,769,385)
Balance at the beginning of the year (in Shares) at Jun. 30, 2020	51,188,564
Sale of common stock, net of issuance costs	$ 7,532	2,992,468		3,000,000
Sale of common stock, net of issuance costs (in shares)	7,532,010
Stock options granted to employees and consultants		420,990		420,990
Net loss			(574,460)	(574,460)
Balance at the end of the year at Sep. 30, 2020	$ 58,721	$ 70,819,714	$ (71,801,290)	$ (922,855)
Balance at the end of the year(in Shares) at Sep. 30, 2020	58,720,574